Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/specific-protection-against-breast-cancers-by-cyclin-d1-ablation-QuC0Hu4Cwx
References (34)
-
P. Sicinski, J. Donaher, Y. Geng, S. Parker, H. Gardner, Mary Park, R. Robker, J. Richards, L. McGinnis, J. Biggers, J. Eppig, R. Bronson, S. Elledge, R. Weinberg (1996)
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesisNature, 384
-
I. Bièche, R. Lidereau (1995)
Genetic alterations in breast cancerGenes, 14
-
Correspondence and requests for materials should be addressed to M.L.L. (email: -
C. Dickson, V. Fantl, C. Gillett, S. Brookes, J. Bartek, R. Smith, C. Fisher, D. Barnes, G. Peters (1995)
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.Cancer letters, 90 1
-
C. Gillett, Paul Smith, W. Gregory, M. Richards, R. Millis, G. Peters, D. Barnes (1996)
Cyclin D1 and prognosis in human breast cancerInternational Journal of Cancer, 69
-
A. Robles, M. Rodriguez-Puebla, A. Glick, C. Trempus, L. Hansen, P. Sicinski, R. Tennant, R. Weinberg, S. Yuspa, C. Conti (1998)
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo.Genes & development, 12 16
-
P. Janes, R. Daly, A. deFazio, R. Sutherland (1994)
Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.Oncogene, 9 12
-
T. Wang, R. Cardiff, L. Zukerberg, E. Lees, A. Arnold, E. Schmidt (1994)
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic miceNature, 369
-
T. Stewart, P. Pattengale, P. Leder (1984)
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genesCell, 38
-
R. Ball, R. Friis, Cora Schoenenberger, W. Doppler, B. Groner (1988)
Prolactin regulation of beta‐casein gene expression and of a cytosolic 120‐kd protein in a cloned mouse mammary epithelial cell line.The EMBO Journal, 7
-
J. Bártková, J. Lukas, H. Müller, Dorrit Lützhøt, M. Strauss, J. Bartek (1994)
Cyclin D1 protein expression and function in human breast cancerInternational Journal of Cancer, 57
-
A. Tsukamoto, R. Grosschedl, R. Guzman, T. Parslow, H. Varmus (1988)
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female miceCell, 55
-
J. Filmus, A. Robles, Wen Shi, M. Wong, L. Colombo, C. Conti (1994)
Induction of cyclin D1 overexpression by activated ras.Oncogene, 9 12
-
E. Sinn, W. Muller, P. Pattengale, I. Tepler, R. Wallace, P. Leder (1987)
Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivoCell, 49
-
E. Santoni-Rugiu, J. Falck, N. Mailand, J. Bartek, J. Lukas (2000)
Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F PathwayMolecular and Cellular Biology, 20
-
J. Lukas, J. Bártková, M. Welcker, O. Petersen, G. Peters, M. Strauss, J. Bartek (1995)
Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.Oncogene, 10 11
-
C. Sherr, James Roberts (1999)
CDK inhibitors: positive and negative regulators of G1-phase progression.Genes & development, 13 12
-
Y. Geng, Wendy Whoriskey, Mary Park, R. Bronson, R. Medema, Tiansen Li, R. Weinberg, P. Sicinski (1999)
Rescue of Cyclin D1 Deficiency by Knockin Cyclin ECell, 97
-
Jan‐Jan Liu, Jyh-Rong Chao, MING-CHUNG Jiang, S. Ng, J. Yen, H. Yang-Yen (1995)
Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cellsMolecular and Cellular Biology, 15
-
J. Lavoie, G. l'Allemain, A. Brunet, R. Müller, J. Pouysségur (1996)
Cyclin D1 Expression Is Regulated Positively by the p42/p44MAPK and Negatively by the p38/HOGMAPK Pathway*The Journal of Biological Chemistry, 271
-
Cheryl Ilkii, Vera Fanti, Rosali Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes, G. Peters (1994)
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.Cancer research, 54 7
-
K. Alevizopoulos, J. Vlach, S. Hennecke, B. Amati (1997)
Cyclin E and c‐Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteinsThe EMBO Journal, 16
-
D. Weinstat-Saslow, M. Merino, R. Manrow, J. Lawrence, R. Bluth, Karl Wittenbel, J. Simpson, D. Page, P. Steeg (1995)
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesionsNature Medicine, 1
-
Weinberg for help; P. Leder for SH1.1 and 13Ma1a cell lines; J. Direnzo and M. Brown for the HC11 cell line; and R. A. Weinberg for pBabe-puro-Ras-V12 and pSVNeuT plasmids -
W. Muller, E. Sinn, P. Pattengale, R. Wallace, P. Leder (1988)
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogeneCell, 54
-
V. Fantl, G. Stamp, A. Andrews, I. Rosewell, C. Dickson (1995)
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.Genes & development, 9 19
-
G. McIntosh, Johnathan Anderson, I. Milton, M. Steward, A. Parr, M. Thomas, J. Henry, B. Angus, T. Lennard, C. Horne (1995)
Determination of the prognostic value of cyclin D1 overexpression in breast cancer.Oncogene, 11 5
-
C. Albanese, J. Johnson, G. Watanabe, Nathan Eklund, D. Vu, A. Arnold, R. Pestell (1995)
Transforming p21ras Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions (*)The Journal of Biological Chemistry, 270
-
P. Sicinski, J. Donaher, S. Parker, Tiansen Li, Amin Fazeli, H. Gardner, S. Haslam, R. Bronson, S. Elledge, R. Weinberg (1995)
Cyclin D1 provides a link between development and oncogenesis in the retina and breastCell, 82
-
O. Tetsu, F. McCormick (1999)
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.Nature, 398 6726
-
Richard Lee, C. Albanese, M. Fu, M. D’Amico, Bing Lin, G. Watanabe, G. Haines, P. Siegel, M. Hung, Y. Yarden, J. Horowitz, W. Muller, R. Pestell (2000)
Cyclin D1 Is Required for Transformation by Activated Neu and Is Induced through an E2F-Dependent Signaling PathwayMolecular and Cellular Biology, 20
-
(1999)
Genes Dev -
R. Rimerman, Anna Gellert-Randleman, J. Diehl (2000)
Wnt1 and MEK1 Cooperate to Promote Cyclin D1 Accumulation and Cellular Transformation*The Journal of Biological Chemistry, 275
-
Cori Bargmann, M. Hung, R. Weinberg (1986)
Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 45
- Publisher
- Springer Journals
- Copyright
- Copyright © 2001 by Macmillan Magazines Ltd.
- Subject
- Science, Humanities and Social Sciences, multidisciplinary; Science, Humanities and Social Sciences, multidisciplinary; Science, multidisciplinary
- ISSN
- 0028-0836
- eISSN
- 1476-4687
- DOI
- 10.1038/35082500
- Publisher site
- See Article on Publisher Site
Abstract
Breast cancer is the most common malignancy among women. Most of these cancers overexpress cyclin D1, a component of the core cell-cycle machinery. We previously generated mice lacking cyclin D1 using gene targeting. Here we report that these cyclin D1-deficient mice are resistant to breast cancers induced by the neu and ras oncogenes. However, animals lacking cyclin D1 remain fully sensitive to other oncogenic pathways of the mammary epithelium, such as those driven by c-myc or Wnt-1. Our analyses revealed that, in mammary epithelial cells, the Neu–Ras pathway is connected to the cell-cycle machinery by cyclin D1, explaining the absolute dependency on cyclin D1 for malignant transformation in this tissue. Our results suggest that an anti-cyclin D1 therapy might be highly specific in treating human breast cancers with activated Neu–Ras pathways.
Journal
Nature – Springer Journals
Published: Jun 28, 2001